Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 7/2006

01-07-2006 | Letter

Comment to: Hoi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B (2005) The Somogyi phenomenon revisited using continuous glucose monitoring in daily life. Diabetologia 48:2437–2438

Authors: I. Iseda, P. E. Lins, U. Adamson, M. Kollind

Published in: Diabetologia | Issue 7/2006

Login to get access

Excerpt

To the Editor:Using a continuous glucose monitoring system (CGMS), Hoi-Hansen and coworkers [1] recently rejected the existence of the Somogyi phenomenon, having analysed valid glucose data obtained in a large group of type 1 diabetic patients, representing 594 nights. We believe this is an important paper since, in our experience, health care professionals frequently believe that the Somogyi phenomenon exists. Because it remains an important issue, we investigated this concept further. …
Literature
1.
Hoi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B (2005) The Somogyi phenomenon revisited using continuous glucose monitoring in daily life. Diabetologia 48:2437–2438CrossRefPubMed
2.
3.
4.
Kollind M, Adamson U, Lins PE (1988) Studies of insulin resistance following hypoglycemia in insulin-dependent diabetes mellitus. Acta Med Scand 223:153–157PubMedCrossRef
5.
Perriello G, De Feo P, Torlone E et al (1988) The effect of asymptomatic nocturnal hypoglycemia on glycemic control in diabetes mellitus. N Engl J Med 319:1233–1239PubMedCrossRef
6.
Adamson U, Cerasi E (1975) Acute effects of exogenous growth hormone in man: time- and dose-bound modification of glucose tolerance and glucose-induced insulin release. Acta Endocrinol (Copenhagen) 80:247–261
7.
Lerman IG, Wolfsdorf JI (1988) Relationship of nocturnal hypoglycemia to daytime glycemia in IDDM. Diabetes Care 11:636–642PubMedCrossRef
8.
Hirsch IB, Smith LJ, Havlin CE, Shah SD, Clutter WE, Cryer PE (1990) Failure of nocturnal hypoglycemia to cause daytime hyperglycemia in patients with IDDM. Diabetes Care 13:133–142PubMedCrossRef
Metadata
Title
Comment to: Hoi-Hansen T, Pedersen-Bjergaard U, Thorsteinsson B (2005) The Somogyi phenomenon revisited using continuous glucose monitoring in daily life. Diabetologia 48:2437–2438
Authors
I. Iseda
P. E. Lins
U. Adamson
M. Kollind
Publication date
01-07-2006
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2006
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0238-z

Other articles of this Issue 7/2006

Diabetologia 7/2006 Go to the issue

Article

Common variants in MODY genes increase the risk of gestational diabetes mellitus

Review

PGC-1α: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes

Article

Intracellular ATP-sensitive K+ channels in mouse pancreatic beta cells: against a role in organelle cation homeostasis

Article

Association of soluble CD40 ligand with carotid atherosclerosis in Japanese type 1 diabetic patients

Article

Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour?

Article

Prolactin regulatory element binding protein as a potential transcriptional factor for the insulin gene in response to glucose stimulation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits